The Claim
Unsweetened caffeinated coffee consumption is associated with a dose-dependent reduction in neurodegenerative disease risk, with the greatest reduction observed at a consumption level of at least three cups per day, indicating a potential threshold effect for neuroprotection.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People who drink at least three cups of unsweetened caffeinated coffee per day have a lower risk of neurodegenerative diseases compared to those who drink less.
See the scientific wording
The association between unsweetened caffeinated coffee consumption and reduced neurodegenerative disease risk appears dose-dependent, with the greatest benefit observed at ≥3 cups per day, suggesting a threshold effect may exist for neuroprotection.
Caffeine stops a brain chemical called adenosine from binding to its receptors, which reduces inflammation in brain cells and helps energy factories inside neurons work better. This keeps neurons alive longer and prevents the buildup of harmful proteins that damage the brain.
What the research says
1 studyPeople who drank three or more cups of black, unsweetened coffee a day were less likely to get Alzheimer’s or Parkinson’s disease than those who didn’t drink coffee, and the more they drank (up to three cups), the lower their risk.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.